Skip to content

Medpace Voice

Tag: Central Nervous System

Clinical Development

Q&A with Dr. Richard Scheyer: Novel Approaches to Confirming CNS Penetration and Target Engagement

  • May 29, 2018

Richard Scheyer, MD, Vice President, Medical Affairs at Medpace answers some questions about his upcoming presentation about CNS-targeted therapies at DIA 2018.

Clinical Development

How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 3

  • April 18, 2018

In our previous post, we discussed the approaches to help you identify, enroll and retain rare disease populations in clinical trials. Once the right patients…